Dataset Information

Natural triterpenoids from licorice potently inhibit SARS-CoV-2 infection.

ABSTRACT:

Introduction

The COVID-19 global epidemic caused by severe acute respiratory syndrome coronavirus (SARS-CoV-2) is a great public health emergency. Discovering antiviral drug candidates is urgent for the prevention and treatment of COVID-19.

Objectives

This work aims to discover natural SARS-CoV-2 inhibitors from the traditional Chinese herbal medicine licorice.

Methods

We screened 125 small molecules from Glycyrrhiza uralensis Fisch. (licorice, Gan-Cao) by virtual ligand screening targeting the receptor-binding domain (RBD) of SARS-CoV-2 spike protein. Potential hit compounds were further evaluated by ELISA, SPR, luciferase assay, antiviral assay and pharmacokinetic study.

Results

The triterpenoids licorice-saponin A3 (A3) and glycyrrhetinic acid (GA) could potently inhibit SARS-CoV-2 infection, with EC₅₀ of 75 nM and 3.17 µM, respectively. Moreover, we reveal that A3 mainly targets the nsp7 protein, and GA binds to the spike protein RBD of SARS-CoV-2.

Conclusion

In this work, we found GA and A3 from licorice potently inhibit SARS-CoV-2 infection by affecting entry and replication of the virus. Our findings indicate that these triterpenoids may contribute to the clinical efficacy of licorice for COVID-19 and could be promising candidates for antiviral drug development.

SUBMITTER: Yi Y

PROVIDER: S-EPMC8620242 | biostudies-literature | 2022 Feb

REPOSITORIES: biostudies-literature

ACCESS DATA

Publications

Natural triterpenoids from licorice potently inhibit SARS-CoV-2 infection.

Yi Yang Y Li Junhua J Lai Xinyuan X Zhang Meng M Kuang Yi Y Bao Yang-Oujie YO Yu Rong R Hong Wei W Muturi Elishiba E Xue Heng H Wei Hongping H Li Tong T Zhuang Hui H Qiao Xue X Xiang Kuanhui K Yang Hang H Ye Min M

Journal of advanced research 20211126

<h4>Introduction</h4>The COVID-19 global epidemic caused by severe acute respiratory syndrome coronavirus (SARS-CoV-2) is a great public health emergency. Discovering antiviral drug candidates is urgent for the prevention and treatment of COVID-19.<h4>Objectives</h4>This work aims to discover natural SARS-CoV-2 inhibitors from the traditional Chinese herbal medicine licorice.<h4>Methods</h4>We screened 125 small molecules from <i>Glycyrrhiza uralensis</i> Fisch. (licorice, Gan-Cao) by virtual li ...[more]

PMID: 35116174

Similar Datasets

Project description:The severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), known to cause the disease COVID-19, was declared a pandemic in early 2020. The objective of this review was to collate information regarding the potential of plants and natural products to inhibit coronavirus and targets associated with infection in humans and to highlight known drugs, which may have potential activity against SARS-CoV-2. Due to the similarity in the RNA genome, main proteases, and primary host receptor between SARS-CoV and SARS-CoV-2, a review was conducted on plants and secondary metabolites, which have shown activity against SARS-CoV. Numerous scientific reports on the potential of plants and secondary metabolites against SARS-CoV infection were found, providing important information on their possible activity against SARS-CoV-2. Based on current literature, 83 compounds have been identified with the potential to inhibit COVID-19. The most prominent selectivity was found for the alkaloid, lycorine, the lignan, savinin, and the abietane terpenoid, 8-beta-hydroxyabieta-9(11),13-dien-12-one with selectivity index values greater than 945, 667, and 510, respectively. Plants and their secondary metabolites, with activity against targets associated with the SARS-CoV infection, could provide valuable leads for the development into drugs for the novel SARS-CoV-2. The prospects of using computational methods to screen secondary metabolites against SARS-CoV targets are briefly discussed, and the drawbacks have been highlighted. Finally, we discuss plants traditionally used in Southern Africa for symptoms associated with respiratory viral infections and influenza, such as coughs, fever, and colds. However, only a few of these plants have been screened against SARS-CoV. Natural products hold a prominent role in discovering novel therapeutics to mitigate the current COVID-19 pandemic; however, further investigations regarding in vitro, in vivo, pre-clinical, and clinical phases are still required.

Dataset Information

Natural triterpenoids from licorice potently inhibit SARS-CoV-2 infection.

Introduction

Objectives

Methods

Results

Conclusion

Publications

Natural triterpenoids from licorice potently inhibit SARS-CoV-2 infection.

Similar Datasets

OmicsDI is part of the ELIXIR infrastructure

Tweets